Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
07/2004
07/06/2004US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/06/2004US6759477 Method for preparing imides from sulfonyl fluorides
07/06/2004US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
07/01/2004WO2003045878A8 2,w-diaminocarboxylic acid compounds
07/01/2004US20040127664 Adhesives and sealants
07/01/2004US20040127574 Aminoethanol derivatives
07/01/2004US20040127570 inhibitors of protein-tyrosine phosphatases
07/01/2004US20040127560 compounds with high binding affinity for the glucagon receptor, such as: 3-{4-[1-(4-cyclohexylphenyl)-3-(3-trifluoromethoxyphenyl)ureidomethyl]benzoylamino}propionic acid; antidiabetic agents; antiobesity agent; antihypertensive agent
07/01/2004US20040127533 Sulfonamide derivatives
07/01/2004US20040127518 For therapy of anxiety or pain, and other neurological, sleep, or psychological disorders, for inducing sleep, for treating glaucoma, and controlling appetite or appetive disorders
07/01/2004US20040127495 Preferential suppressors of immunoglobulins, used as immunosuppressants and antiallergens
07/01/2004US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome
07/01/2004US20040127488 For therapy of HIV virus infection in a human
06/2004
06/30/2004EP1433778A1 Use of nitriles as rotamase inhibitors
06/30/2004EP1432693A2 Mch receptor antagonists
06/30/2004EP1432674A2 Hydroxypropylamines
06/30/2004EP1149072B1 Sulfonamide hydroxamates
06/30/2004EP1009743B1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
06/30/2004CN1509269A 磺酰胺衍生物 Sulfonamide derivatives
06/30/2004CN1509204A Bis (perfluoroalkanesulfonyl)imides and their salts as surfactants/additives for applications having extreme environments and methods thereof
06/29/2004US6756504 Enzyme inhibitors of various lipid- related enzymes, reducing lipid accumulation, anticancer agents, antimalaria agents, antiprotozoa agents, antilipolytic agents
06/29/2004US6756409 For therapy and prophylaxis of pain and/or neurodegenerative disorders
06/24/2004WO2004052847A2 Tricyclic steroid hormone nuclear receptor modulators
06/24/2004WO2004052830A1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases
06/24/2004WO2004052357A1 Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases
06/24/2004WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/24/2004US20040122256 forms a fluoropolymer with excellent heat resistance and high proton conductivity and a solid polymer electrolyte membrane for example fuel cells; chemical intermediates
06/24/2004US20040122064 Enzyme inhibitors of both wild type and mutant variants of HIV reverse transcriptase, particularly resistant varieties; e.g.,N-{4-[(acetylamino)sulfonyl]-2-methylphenyl}-2-[4-chloro-2-(3-cyano-5-methylbenzoyl)phenoxy]acetamide
06/24/2004US20040118318 Alkylamine derivatives as antifouling agents
06/24/2004DE10258695A1 New 2-(2-hydroxy-2-(3-methylsulfonylamino-4-hydroxyphenyl)ethylamino-4-(pyrid-2-ylamino)-2-methylbutane used e.g. for treating asthma and chronic obstructive pulmonary disease
06/24/2004CA2508663A1 Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases
06/23/2004EP1431267A1 Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
06/23/2004EP1430028A2 Aromatic and heteroaromatic acid halides for synthesizing polyamides
06/23/2004EP1430019A1 Sphingolipids
06/23/2004EP1429765A2 Inhibitors of histone deacetylase
06/23/2004EP1076644B1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
06/23/2004EP0966424B1 Aminobenzophenones as inhibitors of interleukin and tnf
06/22/2004US6753380 May be applied as coatings or incorporated as melt additives the fluorochemical compositions impart oil and water repellency to the substrate
06/22/2004CA2135491C Process for preparing substituted aromatic amines
06/17/2004WO2004050606A1 PROCESS FOR THE SYNTHESIS OF N-SUBSTITUTED β-AMINO NITRILES THROUGH THE RING OPENING OF AZIRIDINES
06/17/2004WO2004034999A3 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
06/17/2004WO2004018414A3 Antibacterial agents
06/17/2004US20040116399 for preventing or treating coagulation disorders
06/17/2004US20040116355 Caspase inhibitors and the use thereof
06/17/2004US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
06/16/2004EP1428817A1 ACID AMIDE DERIVATIVES, PROCESS FOR PRODUCING THESE, AND PEST CONTROL AGENT CONTAINING THESE
06/16/2004EP1427699A1 Selective herbicides based on substituted arylsulfonylaminocarbonyl triazolinones and safeners
06/16/2004EP1095071B1 Aromatic polymers with pendant fluorinated ionic groups
06/16/2004EP0973730B1 Calcilytic compounds
06/16/2004CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds
06/15/2004US6750369 Substituted amino acids as erythropoietin mimetics
06/15/2004US6750253 Aminobenzophenones as inhibitors of il-1β and tnf-α
06/15/2004US6750217 Anticancer agents; cardiovascular disorders; kinase inhibitor
06/10/2004WO2004048329A1 Antitumor benzoylsulfonamides
06/10/2004WO2004048309A1 Vitamin d receptor modulators
06/10/2004WO2004027388A3 Novel green and orange fluorescent labels and their uses
06/10/2004WO2004016578A3 Arylethanolamine beta2-adrenoreceptor agonist compounds
06/10/2004WO2003048116A3 Esters and amides as ppar-alpha agonists ____________
06/10/2004US20040110954 Methods of synthesizing phenol-contining compounds
06/10/2004US20040110839 Compounds and compositions for delivering active agents
06/10/2004US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
06/10/2004US20040110830 20-hydroxyeicosatetraenoic acid (HETE); useful as therapeutic agents for kidney diseases, cerebrovascular diseases, or circulatory diseases
06/10/2004US20040110753 Tyrosine derivatives
06/10/2004US20040110736 Cyclic derivatives as modulators of chemokine receptor activity
06/09/2004EP1425258A2 Hydroxyeicosenoic acid analogs
06/09/2004EP1425001A1 Phenethanolamine derivatives for treatment of respiratory diseases
06/09/2004EP1235797B1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode
06/09/2004EP1019364B1 Inhibitors of protein tyrosine phosphatase
06/09/2004CN1503774A Carboxylic acid derivative and thereof
06/09/2004CN1152857C Phenylsulfonamide-phenylethylamines useful as dopamine receptors
06/08/2004US6747149 Glucamine salts for treating hepatitis virus infections
06/08/2004US6747027 Selectively inhibits in vitro activity of human matrix metalloprotease-13 over in vitro activity of human matrix metalloprotease-1
06/08/2004CA2079692C Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
06/03/2004WO2004046093A1 Novel complex-forming agents
06/03/2004WO2004033418A3 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists
06/03/2004WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase
06/03/2004US20040106806 derivatives of hydroxy-pyrene trisulphonic and disulphonic acids
06/03/2004US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
06/03/2004US20040106792 Biphenyl compound
06/03/2004US20040106613 For treating sickle cell disease and glaucoma.
06/03/2004US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent
06/03/2004US20040106558 Hydroxamate-containing cysteine and serine protease inhibitors
06/02/2004EP1424329A1 Method of preparing 4-(imidazole-1-il)benzenesulphonamide derivatives
06/02/2004EP1423379A1 Ortho-substituted aryl amides for controlling invertebrate pests
06/02/2004EP1423356A2 Novel aminobenzoephenones
06/02/2004EP1423004A1 Herbicidal n-alkylsulfonamino derivatives
06/02/2004CN1501911A Phenethanolamine derivatives for treatment of respiratory diseases
06/02/2004CN1151836C Compounds and compositions for delivering active agents
06/01/2004US6743790 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
05/2004
05/27/2004WO2004043939A1 Amide compounds and methods of using the same
05/27/2004WO2004043916A1 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
05/27/2004WO2004043911A2 N-cycloalkylglycines as hiv protease inhibitors
05/27/2004WO2004043355A2 Alpha, alpha-disubstituted benzylglycine derivatives as hiv protease inhibitors
05/27/2004WO2004029019A3 Compounds for the treatment of alzheimer’s disease
05/27/2004WO2003073986A3 Aminoalkylphosphonates and related compounds as edg receptor agonists
05/27/2004US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease
05/27/2004US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
05/27/2004US20040102521 Excitatory amino acid receptor modulators
05/27/2004US20040102513 2'-Substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
05/27/2004US20040102496 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 177